Susana
Ravassa Albéniz
Profesional Investigadora
Berlin Institute of Health
Berlín, AlemaniaPublications en collaboration avec des chercheurs de Berlin Institute of Health (1)
2022
-
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331